HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.

AbstractOBJECTIVE:
To assess the production mechanism of anti-GQ1b autoantibody in Fisher syndrome (FS).
METHODS:
The authors conducted a prospective case-control serologic study of five antecedent infections (Campylobacter jejuni, cytomegalovirus, Epstein-Barr virus, Mycoplasma pneumoniae, and Haemophilus influenzae) in 73 patients with FS and 73 sex- and age-matched hospital controls (HCs). Serologic evidence in FS patients of C. jejuni (21%) and H. influenzae (8%) infections was present significantly more often than in the HCs. None of the five pathogens examined was found in the 49 (67%) patients with FS. Anti-GQ1b IgG antibody was detected in most FS patients infected with C. jejuni or H. influenzae. Mass spectrometry analysis identified a C. jejuni strain (CF93-6) carrying a GT1a-like lipo-oligosaccharide (LOS) that had been isolated from an FS patient. Immunization of complex ganglioside-lacking knockout mice with the GT1a-like LOS generated IgG class monoclonal antibodies (mAbs) that reacted with GQ1b and GT1a. Thin-layer chromatography with immunostaining showed that anti-GQ1b mAb bound to the C. jejuni LOS (50% of the 20 FS-related strains) more commonly than in the Guillain-Barré syndrome (GBS)-related (7% of 70) or enteritis-related (20% of 65) strains. Anti-GM1 and anti-GD1a mAbs also reacted with the LOS from some FS-related strains (both 20%), but binding frequencies were higher in the GBS-related strains (74 and 57%). The GQ1b epitope was detected in 4 (40%) of the 10 FS-related H. influenzae strains but was absent in strains from patients with GBS (n = 4) and uncomplicated respiratory infections (n = 10).
CONCLUSIONS:
C. jejuni and H. influenzae are related to Fisher syndrome (FS) development, and production of anti-GQ1b autoantibody is mediated by the GQ1b-mimicking lipo-oligosaccharides on those bacteria. The causative agents remain unclear in the majority of patients with FS.
AuthorsM Koga, M Gilbert, J Li, S Koike, M Takahashi, K Furukawa, K Hirata, N Yuki
JournalNeurology (Neurology) Vol. 64 Issue 9 Pg. 1605-11 (May 10 2005) ISSN: 1526-632X [Electronic] United States
PMID15883324 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Gangliosides
  • Lipopolysaccharides
  • lipid-linked oligosaccharides
  • GT1aalpha ganglioside
  • GQ1b ganglioside
Topics
  • Adult
  • Animals
  • Autoantibodies (blood, immunology)
  • Campylobacter Infections (complications, immunology)
  • Campylobacter jejuni (immunology)
  • Case-Control Studies
  • Cytomegalovirus Infections (complications, immunology)
  • Epstein-Barr Virus Infections (complications, immunology)
  • Female
  • Gangliosides (immunology)
  • Haemophilus Infections (complications, immunology)
  • Haemophilus influenzae (immunology)
  • Humans
  • Lipopolysaccharides (immunology)
  • Male
  • Mice
  • Mice, Knockout
  • Middle Aged
  • Miller Fisher Syndrome (blood, immunology, virology)
  • Molecular Mimicry (immunology)
  • Mycoplasma Infections (complications, immunology)
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: